Chronic pain patients often suffer from impaired cognitive function as a side effect of their pain. That degradation isn’t addressed by pain-relief medications, some of which can even make the deficit worse.
Researchers at The University of Texas at Dallas have pinpointed a single biochemical pathway as a target for addressing both this neuropathic pain and the accompanying cognitive problems.
